Prognostic Significance of Urinary Biomarkers in Patients Hospitalized With COVID-19
Steven Menez, Dennis G. Moledina, Heather Thiessen‐Philbrook, F. Perry Wilson, Wassim Obeid, Michael Simonov, Yu Yamamoto, Celia P. Corona‐Villalobos, Crystal Chang, Brian T. Garibaldi, William Clarke, Shelli Farhadian, Charles S. Dela Cruz, Steven G. Coca, Chirag R. Parikh, Albert I. Ko, Akiko Iwasaki, Shelli Farhadian, Allison Nelson, Arnau Casanovas‐Massana, Elizabeth B. White, Wade L. Schulz, Andreas Coppi, Patrick Young, Ángela Núñez, Denise Shepard, Irene Matos, Yvette Strong, Kelly Anastasio, Kristina Brower, Maxine Kuang, Michael Chiorazzi, Santos Bermejo, Pavithra Vijayakumar, Bertie Geng, John Fournier, Maksym Minasyan, M. Catherine Muenker, Adam J. Moore, Girish N. Nadkarni
Topics & Concepts
MedicineAcute kidney injuryBiomarkerKidney diseaseInternal medicineUrinary systemProportional hazards modelDialysisCohortLipocalinCohort studyRisk factorBiochemistryChemistryCOVID-19 Clinical Research StudiesAcute Kidney Injury ResearchCOVID-19 and healthcare impacts